Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Stuttgart - Delayed Quote EUR

Creo Medical Group PLC (1RC.SG)

Compare
0.1340
-0.0310
(-16.76%)
As of 1:09:40 PM GMT+2. Market Open.
Currency in GBP All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
30,800
30,800
27,200
25,161
9,429
Cost of Revenue
15,500
15,500
14,000
13,576
5,394
Gross Profit
15,300
15,300
13,200
11,585
4,035
Operating Expense
40,100
40,100
43,900
41,492
27,519
Operating Income
-24,800
-24,800
-30,700
-29,907
-23,484
Net Non Operating Interest Income Expense
300
300
-200
-332
5
Pretax Income
-24,500
-24,500
-30,900
-30,339
-23,462
Tax Provision
-2,800
-2,800
-4,000
-5,744
-3,146
Net Income Common Stockholders
-21,700
-21,700
-26,900
-24,595
-20,316
Diluted NI Available to Com Stockholders
-21,700
-21,700
-26,900
-24,595
-20,316
Basic EPS
-0.07
-0.07
-0.14
-0.14
-0.13
Diluted EPS
-0.07
-0.07
-0.14
-0.14
-0.13
Basic Average Shares
313,004.3990
313,004.3990
187,894.5990
170,381.4560
161,575.4410
Diluted Average Shares
313,004.3990
313,004.3990
187,894.5990
170,381.4560
161,575.4410
Total Operating Income as Reported
-24,800
-24,800
-30,700
-29,907
-23,484
Total Expenses
55,600
55,600
57,900
55,068
32,913
Net Income from Continuing & Discontinued Operation
-21,700
-21,700
-26,900
-24,595
-20,316
Normalized Income
-21,700
-21,700
-26,900
-24,513.9327
-20,330.7205
Interest Income
700
700
100
31
178
Interest Expense
400
400
300
363
173
Net Interest Income
300
300
-200
-332
5
EBIT
-24,100
-24,100
-30,600
-29,976
-23,289
EBITDA
-20,700
-20,700
-27,500
-27,414
-21,693
Reconciled Cost of Revenue
15,500
15,500
14,000
13,576
5,394
Reconciled Depreciation
3,400
3,400
3,100
2,562
1,596
Net Income from Continuing Operation Net Minority Interest
-21,700
-21,700
-26,900
-24,595
-20,316
Total Unusual Items Excluding Goodwill
--
--
--
-100
17
Total Unusual Items
--
--
--
-100
17
Normalized EBITDA
-20,700
-20,700
-27,500
-27,314
-21,710
Tax Rate for Calcs
0.0001
0.0001
0.0001
0.0002
0.0001
Tax Effect of Unusual Items
--
--
--
-18.9327
2.2795
12/31/2020 - 8/28/2017

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade